| A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019 S Jugl, A Okpeku, B Costales, EJ Morris, G Alipour-Haris, ... Medical Cannabis and Cannabinoids 4 (1), 21-42, 2021 | 41 | 2021 |
| for Migraine HC Diener Eur Neurol 34 (2), 18-25, 1994 | 29* | 1994 |
| Much ado about dosing: the needs and challenges of defining a standardized cannabis unit S Jugl, R Sajdeya, EJ Morris, AJ Goodin, JD Brown Medical cannabis and cannabinoids 4 (2), 121-124, 2021 | 23 | 2021 |
| Developing and validating a natural language processing algorithm to extract preoperative cannabis use status documentation from unstructured narrative clinical notes R Sajdeya, MT Mardini, PJ Tighe, RL Ison, C Bai, S Jugl, G Hanzhi, ... Journal of the American Medical Informatics Association 30 (8), 1418-1428, 2023 | 10 | 2023 |
| Practice patterns and training needs among physicians certifying patients for medical marijuana in Florida R Sajdeya, A Shavers, J Jean-Jacques, B Costales, S Jugl, C Crump, ... Journal of Primary Care & Community Health 12, 21501327211042790, 2021 | 8 | 2021 |
| A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019. Medical Cannabis and Cannabinoids … S Jugl, A Okpeku, B Costales, EJ Morris, G Alipour-Haris, ... | 8 | 2021 |
| Climbing the evidence pyramid: dosing considerations for medical cannabis in the management of chronic pain S Jugl, AJ Goodin, JD Brown Medical Cannabis and Cannabinoids 6 (1), 41-45, 2023 | 7 | 2023 |
| Priorities for medical marijuana research from the perspective of physicians, dispensary owners/staff, and patients: a survey study J Jean-Jacques, R Cook, AG Winterstein, A Goodin, JD Brown, S Jugl, ... Medical Cannabis and Cannabinoids 4 (2), 107-113, 2021 | 6 | 2021 |
| Prenatal Exposure to Valproic Acid Across Various Indications for Use NE Smolinski, A Sarayani, TN Thai, S Jugl, CLY Ewig, AG Winterstein JAMA Network Open 7 (5), e2412680-e2412680, 2024 | 4 | 2024 |
| Clinical considerations for cannabis use and cardiovascular health R Sajdeya, S Jugl, R Cook, JD Brown, A Goodin Medical Cannabis and Cannabinoids 5 (1), 120-127, 2022 | 4 | 2022 |
| A systematic review of evidence for cannabis and cannabinoids as adjuvant therapy in palliative and supportive oncology care. S Jugl, S Keshwani, L Adkins, CD Heldermon, A Winterstein, A Goodin Journal of Clinical Oncology 38 (15_suppl), 12091-12091, 2020 | 4 | 2020 |
| Cannabis use and inhalational anesthesia administration in older adults: A propensity-matched retrospective cohort study R Sajdeya, M Rouhizadeh, RL Cook, RL Ison, C Bai, S Jugl, H Gao, ... Anesthesiology 141 (5), 870-880, 2024 | 2 | 2024 |
| Cannabis use and acute postoperative pain outcomes in older adults: a propensity matched retrospective cohort study R Sajdeya, M Rouhizadeh, RL Cook, RL Ison, C Bai, S Jugl, H Gao, ... Regional Anesthesia & Pain Medicine, 2024 | 2 | 2024 |
| Protocol of a Combined Cohort and Cross-Sectional Study of Persons Receiving Medical Cannabis in Florida, USA: The Medical Marijuana and Me (M3) Study R Sajdeya, HJ Fechtel, G Spandau, AJ Goodin, JD Brown, S Jugl, ... Medical Cannabis and Cannabinoids 6 (1), 46-57, 2023 | 2 | 2023 |
| Chronische Herzinsuffizienz> Grundlage: Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz–Langfassung, 3 S Jugl PHARMAKON 8 (5), 1-8, 2020 | 1 | 2020 |
| Atopische Dermatitis L Springer, S Jugl PHARMAKON 13 (1), 1-8, 2025 | | 2025 |
| Legalization of Smokable Medical Cannabis and Changes in the Dispensed Amount of Δ-9 Tetrahydrocannabinol Per Patient S Jugl, R Sajdeya, M Buhlmann, RL Cook, JD Brown, AG Winterstein, ... Cannabis and Cannabinoid Research, 2024 | | 2024 |
| Epilepsie S Jugl, L Springer PHARMAKON 12 (5), 1-8, 2024 | | 2024 |
| Cannabis and Polysubstance Use Disorder Diagnoses in Medicaid By State Medical and Recreational Marijuana Law Status from 2017 to 2020 A Goodin, S Jugl, J Bae, J Jayawardhana, C Delcher 2024 Annual Research Meeting, 2024 | | 2024 |
| Reasons for Use and Perceived Effects of Medical Cannabis: A Cross-Sectional Statewide Survey R Sajdeya, S Jugl, Y Wang, JG Perez, S Maloney, C Lopez-Quintero, ... Medical Cannabis and Cannabinoids 7 (1), 138-148, 2024 | | 2024 |
